Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Jia-Yi Tong"'
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
Obstructive sleep apnea (OSA) accelerates the progression of chronic heart failure (CHF). OSA is characterized by chronic intermittent hypoxia (CIH), and CIH exposure accelerates cardiac systolic dysfunction and cardiac remodeling in a cardiac afterl
Externí odkaz:
https://doaj.org/article/7e1b645fe6574c8783ac7e57fe6d3068
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 6, Iss 10 (2017)
BackgroundIntermittent hypoxia (IH) induced by obstructive sleep apnea is the key factor involved in cardiovascular fibrosis. Under persistent hypoxia condition, endothelial cells respond by endothelial‐to‐mesenchymal transition (EndMT), which is
Externí odkaz:
https://doaj.org/article/09380df357494fa2994761ae3d1b7f67
Publikováno v:
Sleep and Breathing. 27:245-253
The prevalence of sleep-disordered breathing (SDB) is high in patients with heart failure (HF), while the prevalence of SDB in HF with different left ventricular ejection fractions (LVEF) has rarely been reported. We aimed to explore the prevalence a
Autor:
Qin Wei, Xuan Xu, Long Chen, Tao Wang, Liang Xie, Fu-Chao Yu, Si-Fan Song, Zhi-Qiang Sheng, Jia-Yi Tong
Publikováno v:
American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 322:R241-R252
Obstructive sleep apnea (OSA) is an independent risk factor for cardiovascular disease that is characterized by chronic intermittent hypoxia (CIH), and its impact is related to age. This study aims to assess the age-related impact of CIH on cardiac f
Publikováno v:
Clinical cardiology. 45(7)
The prevalence of sleep-disordered breathing (SDB) is closely related to the severity of heart failure (HF), and the severity of HF is different in patients with HF of different etiologies.This study aimed to explore the prevalence of SDB in patients
Publikováno v:
Chinese medical journal. 126(2)
The long-term effects of bone marrow-derived cells (BMC) transplantation in patients with acute myocardial infarction (AMI) have not been established. The present meta-analysis of randomized controlled trials with follow-up ≥ 2 years was performed